<p>在过去的 7 天里，美国市场下跌了 2.6%，但在过去一年中仍上涨了 9.1%，预计收益将以每年 14% 的速度增长。在这种背景下，识别高增长科技股需要寻找具有强大创新潜力和稳健财务健康的公司，这些公司与这些积极的长期增长前景相一致，尽管短期内可能会有波动。</p>
<h3>美国十大高增长科技公司</h3>
<table>
<thead>
<tr>
<th>名称</th>
<th>收入增长</th>
<th>盈利增长</th>
<th>增长评级</th>
</tr>
</thead>
<tbody>
<tr>
<td>超微电脑</td>
<td>26.38%</td>
<td>39.09%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Mereo BioPharma Group</td>
<td>53.62%</td>
<td>66.56%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Ardelyx</td>
<td>20.78%</td>
<td>59.46%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Travere Therapeutics</td>
<td>26.41%</td>
<td>64.47%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>TG Therapeutics</td>
<td>26.46%</td>
<td>38.75%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Alnylam Pharmaceuticals</td>
<td>23.65%</td>
<td>61.11%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>AVITA Medical</td>
<td>27.28%</td>
<td>60.66%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Alkami Technology</td>
<td>20.54%</td>
<td>76.67%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Ascendis Pharma</td>
<td>35.16%</td>
<td>60.26%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Lumentum Holdings</td>
<td>21.59%</td>
<td>110.32%</td>
<td>★★★★★★</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们美国高增长科技和人工智能股票筛选器中的 233 只股票的完整列表。</p>
<p>下面我们重点介绍几只我们独家的筛选器中的最爱。</p>
<h2>LifeMD (NasdaqGM:LFMD)</h2>
<p><strong>Simply Wall St 增长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> LifeMD, Inc. 是一家直接面向患者的远程医疗公司，促进消费者与医疗专业人员之间的联系，以提供美国的医疗服务，市值为 5.2401 亿美元。</p>
<p><strong>运营：</strong> 该公司主要通过其远程医疗服务产生收入，收入为 1.8005 亿美元，Worksimpli 部门贡献了 5395 万美元。</p>
<p>LifeMD 的战略举措，包括最近与诺和诺德的合作以及与 NovoCare Pharmacy 的整合，强调了其扩大体重管理治疗获取渠道的承诺。这一合作不仅增强了 LifeMD 的产品供应，还通过提供从虚拟咨询到处方履行的综合护理模式，巩固了其在远程医疗市场的地位。在财务上，LifeMD 显示出显著的进展；2025 年第一季度的收入从去年的 4414 万美元激增至 6570 万美元，并将 670 万美元的净亏损转变为 138 万美元的净收入。展望未来，该公司将 2025 年的全年收入预测上调至 2.68 亿至 2.75 亿美元，反映出对医疗服务交付和患者参与策略创新驱动的持续增长的信心。</p>
<ul>
<li>点击这里了解 LifeMD 的细微差别，查看我们的详细分析健康报告。</li>
<li>通过我们的详细历史业绩报告评估 LifeMD 的过去表现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/feefdf8c-475e-4a0b-9631-aa0d54962629/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/feefdf8c-475e-4a0b-9631-aa0d54962629/chart/revenue-and-expenses-breakdown"/></p>
<p>截至 2025 年 5 月的 NasdaqGM:LFMD 收入和支出细分</p>
<h2>Exodus Movement (NYSEAM:EXOD)</h2>
<p><strong>Simply Wall St 增长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Exodus Movement, Inc. 是一家专注于区块链和数字资产行业的金融科技公司，市值为 10.1 亿美元。</p>
<p><strong>运营：</strong> Exodus Movement 主要通过数据处理产生收入，收入为 1.2321 亿美元。</p>
<p>Exodus Movement 最近推出的 XO Pay 自托管钱包服务，标志着在增强用户自主权方面的重要进展，消除了第三方交易所。这一创新不仅简化了加密交易过程，还使 Exodus 在技术领域的用户导向金融解决方案中处于领先地位。在财务上，尽管 2025 年第一季度报告了 1287 万美元的净亏损，但年收入增长仍保持强劲，达到 26.1%。公司的战略收购和对未来增长的乐观展望强调了其在高增长科技领域扩大和多样化产品的承诺。</p>
<ul>
<li>解锁我们对 Exodus Movement 股票分析的全面见解，查看此健康报告。</li>
<li>了解 Exodus Movement 的历史表现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/37aba88a-2e2b-43d5-b309-b6c04bac1726/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/37aba88a-2e2b-43d5-b309-b6c04bac1726/chart/earnings-and-revenue-growth"/></p>
<p>截至 2025 年 5 月的 NYSEAM:EXOD 盈利和收入增长</p>
<h2>Calix (NYSE:CALX)</h2>
<p><strong>Simply Wall St 增长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Calix, Inc. 提供云和软件平台、系统及服务，市值约为 30.3 亿美元。</p>
<p><strong>运营：</strong> Calix 主要通过开发、营销和销售通信接入系统和软件产生收入，收入为 8.2545 亿美元。</p>
<p>Calix 最近推出的产品，包括 GigaSpire® 7u6m Wi-Fi 7 扩展器，强调了其在增强宽带服务能力和用户体验方面的战略重点。这一创新是 Calix 更广泛努力的一部分，旨在通过其 Unlimited Subscriber™产品组合赋能宽带服务提供商（BSPs），提供灵活的高级管理服务。在财务上，尽管 2025 年第一季度净亏损为 479 万美元，但该公司显示出韧性，年收入增长率达到 10.5%。此外，Calix 对研发的承诺显而易见，因为它继续投资于支持可扩展增长和服务卓越的新技术和平台，以应对竞争激烈的市场。</p>
<ul>
<li>在这里深入了解 Calix 的具体情况，查看我们的详细健康报告。</li>
<li>查看我们的历史业绩报告，以获取 Calix 过去表现的见解。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7daf7a7a-5397-498a-98d0-b77040f94bd1/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7daf7a7a-5397-498a-98d0-b77040f94bd1/chart/earnings-and-revenue-growth"/></p>
<p>截至 2025 年 5 月的 NYSE:CALX 盈利和收入增长</p>
<h2>总结</h2>
<ul>
<li>在这里开始您的投资之旅，了解我们 233 只美国高增长科技和人工智能股票的精选。</li>
<li>您是否已经将投资组合多样化，涵盖这些公司？利用 Simply Wall St 的投资组合，密切关注影响您投资的市场动态。</li>
<li>利用 Simply Wall St 最大化您的投资潜力，这是一款提供全球市场洞察的综合应用，免费使用。</li>
</ul>
<h2>对其他可能性感兴趣？</h2>
<ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>用显示强劲增长潜力的公司来充实您的投资组合，这些公司得到了分析师和管理层的乐观展望支持。</li>
<li>寻找现金流潜力良好但交易价格低于其公允价值的公司。</li>
</ul>
<p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
<p>如果您想交易 LifeMD，请在专业人士信赖的最低成本平台 Interactive Brokers 开设账户。</p>
<p>IBKR 在 200 多个国家和地区拥有客户，并可访问 160 个市场，让您可以通过一个集成账户交易股票、期权、期货、外汇、债券和基金。</p>
<p>享受无隐藏费用、无账户最低限额，外汇转换率低至 0.03%，远低于大多数经纪商提供的费用。</p>
<p>赞助内容</p>

MREO

超微电脑

LFMD

<p>美国市场在过去一周下跌了 2.6%，但同比仍上涨 9.1%，预计年收益将增长 14%。主要的高增长科技股票包括超微电脑、Mereo Biopharma 和 LifeMD，后者已将 2025 年的收入预测提高至 2.68 亿至 2.75 亿美元。Exodus Movement 和 Calix 尽管近期出现亏损，但也显示出强劲的增长潜力。投资者被鼓励探索 233 只高增长科技和人工智能股票，以寻求多样化和增长机会</p>

<p>Over the last 7 days, the United States market has dropped 2.6%, yet it remains up by 9.1% over the past year with earnings forecasted to grow by 14% annually. In this context, identifying high growth tech stocks involves looking for companies with strong innovation potential and robust financial health that align well with these positive long-term growth prospects despite short-term fluctuations.</p>
<div class="lb-trans"><p>在过去的 7 天里，美国市场下跌了 2.6%，但在过去一年中仍上涨了 9.1%，预计收益将以每年 14% 的速度增长。在这种背景下，识别高增长科技股需要寻找具有强大创新潜力和稳健财务健康的公司，这些公司与这些积极的长期增长前景相一致，尽管短期内可能会有波动。</p>
</div><h3>Top 10 High Growth Tech Companies In The United States</h3>
<div class="lb-trans"><h3>美国十大高增长科技公司</h3>
</div><table>
<thead>
<tr>
<th>Name</th>
<th>Revenue Growth</th>
<th>Earnings Growth</th>
<th>Growth Rating</th>
</tr>
</thead>
<tbody>
<tr>
<td>Super Micro Computer</td>
<td>26.38%</td>
<td>39.09%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Mereo BioPharma Group</td>
<td>53.62%</td>
<td>66.56%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Ardelyx</td>
<td>20.78%</td>
<td>59.46%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Travere Therapeutics</td>
<td>26.41%</td>
<td>64.47%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>TG Therapeutics</td>
<td>26.46%</td>
<td>38.75%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Alnylam Pharmaceuticals</td>
<td>23.65%</td>
<td>61.11%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>AVITA Medical</td>
<td>27.28%</td>
<td>60.66%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Alkami Technology</td>
<td>20.54%</td>
<td>76.67%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Ascendis Pharma</td>
<td>35.16%</td>
<td>60.26%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Lumentum Holdings</td>
<td>21.59%</td>
<td>110.32%</td>
<td>★★★★★★</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>名称</th>
<th>收入增长</th>
<th>盈利增长</th>
<th>增长评级</th>
</tr>
</thead>
<tbody>
<tr>
<td>超微电脑</td>
<td>26.38%</td>
<td>39.09%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Mereo BioPharma Group</td>
<td>53.62%</td>
<td>66.56%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Ardelyx</td>
<td>20.78%</td>
<td>59.46%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Travere Therapeutics</td>
<td>26.41%</td>
<td>64.47%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>TG Therapeutics</td>
<td>26.46%</td>
<td>38.75%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Alnylam Pharmaceuticals</td>
<td>23.65%</td>
<td>61.11%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>AVITA Medical</td>
<td>27.28%</td>
<td>60.66%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Alkami Technology</td>
<td>20.54%</td>
<td>76.67%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Ascendis Pharma</td>
<td>35.16%</td>
<td>60.26%</td>
<td>★★★★★★</td>
</tr>
<tr>
<td>Lumentum Holdings</td>
<td>21.59%</td>
<td>110.32%</td>
<td>★★★★★★</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 233 stocks from our US High Growth Tech and AI Stocks screener.</p>
<div class="lb-trans"><p>点击这里查看我们美国高增长科技和人工智能股票筛选器中的 233 只股票的完整列表。</p>
</div><p>Below we spotlight a couple of our favorites from our exclusive screener.</p>
<div class="lb-trans"><p>下面我们重点介绍几只我们独家的筛选器中的最爱。</p>
</div><h2>LifeMD (NasdaqGM:LFMD)</h2>
<div class="lb-trans"><h2>LifeMD (NasdaqGM:LFMD)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 增长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> LifeMD, Inc. is a direct-to-patient telehealth company facilitating connections between consumers and healthcare professionals for medical care in the United States, with a market cap of $524.01 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> LifeMD, Inc. 是一家直接面向患者的远程医疗公司，促进消费者与医疗专业人员之间的联系，以提供美国的医疗服务，市值为 5.2401 亿美元。</p>
</div><p><strong>Operations:</strong> The company generates revenue primarily from its telehealth services, accounting for $180.05 million, and Worksimpli segment contributing $53.95 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司主要通过其远程医疗服务产生收入，收入为 1.8005 亿美元，Worksimpli 部门贡献了 5395 万美元。</p>
</div><p>LifeMD's strategic maneuvers, including its recent partnership with Novo Nordisk and integration with NovoCare Pharmacy, underscore its commitment to expanding access to weight management treatments. This collaboration not only enhances LifeMD's product offering but also solidifies its position in the telehealth market by providing a comprehensive care model from virtual consultations to prescription fulfillment. Financially, LifeMD has shown significant progress; Q1 2025 revenue surged to $65.7 million from $44.14 million year-over-year, and it flipped a net loss of $6.77 million into a net income of $1.38 million. Looking ahead, the company raised its full-year revenue forecast for 2025 to between $268 million and $275 million, reflecting confidence in continued growth driven by innovations in healthcare delivery and patient engagement strategies.</p>
<div class="lb-trans"><p>LifeMD 的战略举措，包括最近与诺和诺德的合作以及与 NovoCare Pharmacy 的整合，强调了其扩大体重管理治疗获取渠道的承诺。这一合作不仅增强了 LifeMD 的产品供应，还通过提供从虚拟咨询到处方履行的综合护理模式，巩固了其在远程医疗市场的地位。在财务上，LifeMD 显示出显著的进展；2025 年第一季度的收入从去年的 4414 万美元激增至 6570 万美元，并将 670 万美元的净亏损转变为 138 万美元的净收入。展望未来，该公司将 2025 年的全年收入预测上调至 2.68 亿至 2.75 亿美元，反映出对医疗服务交付和患者参与策略创新驱动的持续增长的信心。</p>
</div><ul>
<li>Click here to discover the nuances of LifeMD with our detailed analytical health report.</li>
<li>Assess LifeMD's past performance with our detailed historical performance reports.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里了解 LifeMD 的细微差别，查看我们的详细分析健康报告。</li>
<li>通过我们的详细历史业绩报告评估 LifeMD 的过去表现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/feefdf8c-475e-4a0b-9631-aa0d54962629/chart/revenue-and-expenses-breakdown" alt="" original-src="https://images.simplywall.st/company/feefdf8c-475e-4a0b-9631-aa0d54962629/chart/revenue-and-expenses-breakdown"/></p>
<p>NasdaqGM:LFMD Revenue and Expenses Breakdown as at May 2025</p>
<div class="lb-trans"><p>截至 2025 年 5 月的 NasdaqGM:LFMD 收入和支出细分</p>
</div><h2>Exodus Movement (NYSEAM:EXOD)</h2>
<div class="lb-trans"><h2>Exodus Movement (NYSEAM:EXOD)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 增长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Exodus Movement, Inc. is a financial technology company focused on the blockchain and digital asset industry in the United States, with a market cap of $1.01 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Exodus Movement, Inc. 是一家专注于区块链和数字资产行业的金融科技公司，市值为 10.1 亿美元。</p>
</div><p><strong>Operations:</strong> Exodus Movement generates revenue primarily through data processing, amounting to $123.21 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> Exodus Movement 主要通过数据处理产生收入，收入为 1.2321 亿美元。</p>
</div><p>Exodus Movement's recent launch of XO Pay, a self-custody wallet service, marks a significant stride in enhancing user autonomy by eliminating third-party exchanges. This innovation not only streamlines the crypto transaction process but also positions Exodus at the forefront of user-focused financial solutions in the tech space. Financially, despite a challenging quarter with a net loss reported at $12.87 million for Q1 2025, annual revenue growth remains robust at 26.1%. The company's strategic acquisitions and optimistic outlook on future growth underscore its commitment to expanding and diversifying its offerings within the high-growth tech sector.</p>
<div class="lb-trans"><p>Exodus Movement 最近推出的 XO Pay 自托管钱包服务，标志着在增强用户自主权方面的重要进展，消除了第三方交易所。这一创新不仅简化了加密交易过程，还使 Exodus 在技术领域的用户导向金融解决方案中处于领先地位。在财务上，尽管 2025 年第一季度报告了 1287 万美元的净亏损，但年收入增长仍保持强劲，达到 26.1%。公司的战略收购和对未来增长的乐观展望强调了其在高增长科技领域扩大和多样化产品的承诺。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of Exodus Movement stock in this health report.</li>
<li>Learn about Exodus Movement's historical performance.</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁我们对 Exodus Movement 股票分析的全面见解，查看此健康报告。</li>
<li>了解 Exodus Movement 的历史表现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/37aba88a-2e2b-43d5-b309-b6c04bac1726/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/37aba88a-2e2b-43d5-b309-b6c04bac1726/chart/earnings-and-revenue-growth"/></p>
<p>NYSEAM:EXOD Earnings and Revenue Growth as at May 2025</p>
<div class="lb-trans"><p>截至 2025 年 5 月的 NYSEAM:EXOD 盈利和收入增长</p>
</div><h2>Calix (NYSE:CALX)</h2>
<div class="lb-trans"><h2>Calix (NYSE:CALX)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 增长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Calix, Inc. offers cloud and software platforms, systems, and services globally with a market capitalization of approximately $3.03 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Calix, Inc. 提供云和软件平台、系统及服务，市值约为 30.3 亿美元。</p>
</div><p><strong>Operations:</strong> Calix generates revenue primarily through developing, marketing, and selling communications access systems and software, amounting to $825.45 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> Calix 主要通过开发、营销和销售通信接入系统和软件产生收入，收入为 8.2545 亿美元。</p>
</div><p>Calix's recent product launches, including the GigaSpire® 7u6m Wi-Fi 7 extender, underscore its strategic focus on enhancing broadband service capabilities and subscriber experiences. This innovation is part of Calix's broader effort to empower broadband service providers (BSPs) with flexible, advanced managed services through its Unlimited Subscriber™ portfolio. Financially, despite a net loss of $4.79 million in Q1 2025, the company has shown resilience with a robust annual revenue growth rate of 10.5%. Moreover, Calix's commitment to R&amp;D is evident as it continues to invest in new technologies and platforms that support scalable growth and service excellence in highly competitive markets.</p>
<div class="lb-trans"><p>Calix 最近推出的产品，包括 GigaSpire® 7u6m Wi-Fi 7 扩展器，强调了其在增强宽带服务能力和用户体验方面的战略重点。这一创新是 Calix 更广泛努力的一部分，旨在通过其 Unlimited Subscriber™产品组合赋能宽带服务提供商（BSPs），提供灵活的高级管理服务。在财务上，尽管 2025 年第一季度净亏损为 479 万美元，但该公司显示出韧性，年收入增长率达到 10.5%。此外，Calix 对研发的承诺显而易见，因为它继续投资于支持可扩展增长和服务卓越的新技术和平台，以应对竞争激烈的市场。</p>
</div><ul>
<li>Dive into the specifics of Calix here with our thorough health report.</li>
<li>Review our historical performance report to gain insights into Calix's's past performance.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里深入了解 Calix 的具体情况，查看我们的详细健康报告。</li>
<li>查看我们的历史业绩报告，以获取 Calix 过去表现的见解。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7daf7a7a-5397-498a-98d0-b77040f94bd1/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/7daf7a7a-5397-498a-98d0-b77040f94bd1/chart/earnings-and-revenue-growth"/></p>
<p>NYSE:CALX Earnings and Revenue Growth as at May 2025</p>
<div class="lb-trans"><p>截至 2025 年 5 月的 NYSE:CALX 盈利和收入增长</p>
</div><h2>Summing It All Up</h2>
<div class="lb-trans"><h2>总结</h2>
</div><ul>
<li>Embark on your investment journey to our 233 US High Growth Tech and AI Stocks selection here.</li>
<li>Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.</li>
<li>Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这里开始您的投资之旅，了解我们 233 只美国高增长科技和人工智能股票的精选。</li>
<li>您是否已经将投资组合多样化，涵盖这些公司？利用 Simply Wall St 的投资组合，密切关注影响您投资的市场动态。</li>
<li>利用 Simply Wall St 最大化您的投资潜力，这是一款提供全球市场洞察的综合应用，免费使用。</li>
</ul>
</div><h2>Interested In Other Possibilities?</h2>
<div class="lb-trans"><h2>对其他可能性感兴趣？</h2>
</div><ul>
<li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li>
<li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li>
<li>Find companies with promising cash flow potential yet trading below their fair value.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>用显示强劲增长潜力的公司来充实您的投资组合，这些公司得到了分析师和管理层的乐观展望支持。</li>
<li>寻找现金流潜力良好但交易价格低于其公允价值的公司。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div><p>If you're looking to trade LifeMD, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.</p>
<div class="lb-trans"><p>如果您想交易 LifeMD，请在专业人士信赖的最低成本平台 Interactive Brokers 开设账户。</p>
</div><p>With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.</p>
<div class="lb-trans"><p>IBKR 在 200 多个国家和地区拥有客户，并可访问 160 个市场，让您可以通过一个集成账户交易股票、期权、期货、外汇、债券和基金。</p>
</div><p>Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.</p>
<div class="lb-trans"><p>享受无隐藏费用、无账户最低限额，外汇转换率低至 0.03%，远低于大多数经纪商提供的费用。</p>
</div><p>Sponsored Content</p>
<div class="lb-trans"><p>赞助内容</p>
</div>

US High Growth Tech Stocks to Watch

- 美国市场过去 7 天下跌 2.6%，年涨幅为 9.1%。  
- 高增长科技股需关注创新潜力和财务健康。  
- LifeMD 和 Exodus Movement 等公司展现出强劲的增长前景。

值得关注的美国高增长科技股